158 related articles for article (PubMed ID: 26512634)
1. Poly(Propylene Imine) Dendrimers and Amoxicillin as Dual-Action Antibacterial Agents.
Wrońska N; Felczak A; Zawadzka K; Poszepczyńska M; Różalska S; Bryszewska M; Appelhans D; Lisowska K
Molecules; 2015 Oct; 20(10):19330-42. PubMed ID: 26512634
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-releasing dendrimers as antibacterial agents.
Sun B; Slomberg DL; Chudasama SL; Lu Y; Schoenfisch MH
Biomacromolecules; 2012 Oct; 13(10):3343-54. PubMed ID: 23013537
[TBL] [Abstract][Full Text] [Related]
3. The influence of cationic dendrimers on antibacterial activity of phage endolysin against P. aeruginosa cells.
Ciepluch K; Maciejewska B; Gałczyńska K; Kuc-Ciepluch D; Bryszewska M; Appelhans D; Drulis-Kawa Z; Arabski M
Bioorg Chem; 2019 Oct; 91():103121. PubMed ID: 31310881
[TBL] [Abstract][Full Text] [Related]
4. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
[TBL] [Abstract][Full Text] [Related]
5. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
[TBL] [Abstract][Full Text] [Related]
6. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
[TBL] [Abstract][Full Text] [Related]
7. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
[TBL] [Abstract][Full Text] [Related]
8. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
[TBL] [Abstract][Full Text] [Related]
9. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
[TBL] [Abstract][Full Text] [Related]
10. New surface hydroxylated and internally quaternised poly(propylene imine) dendrimers as efficient biocompatible drug carriers of norfloxacin.
Murugan E; Geetha Rani DP; Srinivasan K; Muthumary J
Expert Opin Drug Deliv; 2013 Oct; 10(10):1319-34. PubMed ID: 23789895
[TBL] [Abstract][Full Text] [Related]
11. Gd-Chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications.
Xiong Z; Wang Y; Zhu J; He Y; Qu J; Effenberg C; Xia J; Appelhans D; Shi X
Biomater Sci; 2016 Oct; 4(11):1622-1629. PubMed ID: 27722500
[TBL] [Abstract][Full Text] [Related]
12. Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: structure-activity studies.
Chen CZ; Beck-Tan NC; Dhurjati P; van Dyk TK; LaRossa RA; Cooper SL
Biomacromolecules; 2000; 1(3):473-80. PubMed ID: 11710139
[TBL] [Abstract][Full Text] [Related]
13. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
[TBL] [Abstract][Full Text] [Related]
14. Structural dependence of in vitro cytotoxicity, oxidative stress and uptake mechanisms of poly(propylene imine) dendritic nanoparticles.
Khalid H; Mukherjee SP; O'Neill L; Byrne HJ
J Appl Toxicol; 2016 Mar; 36(3):464-73. PubMed ID: 26671548
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
[TBL] [Abstract][Full Text] [Related]
16. Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria.
Aelenei P; Rimbu CM; Guguianu E; Dimitriu G; Aprotosoaie AC; Brebu M; Horhogea CE; Miron A
Lett Appl Microbiol; 2019 Feb; 68(2):156-164. PubMed ID: 30471142
[TBL] [Abstract][Full Text] [Related]
17. Influence of surface groups on poly(propylene imine) dendrimers antiprion activity.
McCarthy JM; Rasines Moreno B; Filippini D; Komber H; Maly M; Cernescu M; Brutschy B; Appelhans D; Rogers MS
Biomacromolecules; 2013 Jan; 14(1):27-37. PubMed ID: 23234313
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer.
Gholami M; Mohammadi R; Arzanlou M; Akbari Dourbash F; Kouhsari E; Majidi G; Mohseni SM; Nazari S
BMC Infect Dis; 2017 Jun; 17(1):395. PubMed ID: 28583153
[TBL] [Abstract][Full Text] [Related]
19. Studying complexes between PPI dendrimers and Mant-ATP.
Szulc A; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Fluoresc; 2013 Mar; 23(2):349-56. PubMed ID: 23306952
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on solubility improvement of tetracycline and dexamethasone by poly(propylene imine) and polyamidoamine dendrimers: An insight into cytotoxicity and cell proliferation.
Najafi F; Salami-Kalajahi M; Roghani-Mamaqani H; Kahaie-Khosrowshahi A
J Biomed Mater Res A; 2020 Mar; 108(3):485-495. PubMed ID: 31682311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
